ALKS - Alkermes plc
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$58.29
DETAILS
HIGH:
$65.00
LOW:
$50.00
MEDIAN:
$56.00
CONSENSUS:
$58.29
UPSIDE:
34.06%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 1,312,031 | $68.7M | 0.0% | +601,734 | INCREASED |
| Greenblatt | 11,157 | $584,571 | 0.0% | -30,391 | DECREASED |
| Dalio | 0 | $0 | -- | -83,806 | SOLD |
| Wood | 0 | $0 | -- | -16,500 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-10-07 | Whitaker Anne Clem | director | A-Award | 17,998 | $41.45 | $746K |
| 2026-10-08 | Reed Joshua | officer: SVP, Chief Financial Officer | F-InKind | 4,069 | $40.11 | $163K |
| 2026-10-07 | Whitaker Anne Clem | director | A-Award | 7,239 | -- | -- |
| 2026-10-08 | Reed Joshua | officer: SVP, Chief Financial Officer | M-Exempt | 9,164 | -- | -- |
| 2026-10-02 | Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | SELL | 2,034 | $41.03 | $83K |
| 2026-09-14 | Whitaker Anne Clem | director: | ? | -- | -- | -- |
| 2026-09-03 | Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | SELL | 2,034 | $48.01 | $98K |
| 2026-09-01 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 5,000 | $24.59 | $123K |
| 2026-09-01 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | SELL | 9,000 | $46.99 | $423K |
| 2026-08-17 | Nichols Christian Todd | officer: SVP, Chief Commercial Officer | SELL | 6,912 | $49.19 | $340K |
| 2026-08-17 | Nichols Christian Todd | officer: SVP, Chief Commercial Officer | SELL | 664 | $49.65 | $33K |
| 2026-08-05 | Jackson Blair Curtis | director, officer: President & CEO, Alkermes plc | A-Award | 124,305 | $49.61 | $6.2M |
| 2026-08-05 | Jackson Blair Curtis | director, officer: President & CEO, Alkermes plc | A-Award | 93,229 | $49.61 | $4.6M |
| 2026-08-03 | snyderman nancy lynn MD | director | M-Exempt | 16,524 | $46.72 | $772K |
| 2026-08-03 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | SELL | 9,000 | $48.58 | $437K |
| 2026-08-03 | snyderman nancy lynn MD | director | M-Exempt | 27,948 | $46.72 | $1.3M |
| 2026-08-03 | snyderman nancy lynn MD | director | SELL | 44,472 | $50.35 | $2.2M |
| 2026-08-03 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 4,896 | $24.59 | $120K |
| 2026-08-03 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 104 | $19.34 | $2K |
| 2026-08-03 | Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | SELL | 2,034 | $48.58 | $99K |
| 2026-07-06 | Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | SELL | 2,034 | $54.03 | $110K |
| 2026-07-01 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | SELL | 8,300 | $51.46 | $427K |
| 2026-07-01 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | SELL | 700 | $52.13 | $36K |
| 2026-07-01 | Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 5,000 | $19.34 | $97K |
| 2026-06-12 | Wright Christopher I | director | SELL | 2,000 | $45.10 | $90K |
Congressional Trading
| DATE | MEMBER | CHAMBER | TYPE | AMOUNT |
|---|---|---|---|---|
| 2026-10-12 | Gilbert Cisneros | HOUSE | Purchase | $1,001 - $15,000 |
| 2026-09-07 | Gilbert Ray Cisneros | HOUSE | Purchase | $15,001 - $50,000 |